{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:58:30Z","timestamp":1740146310913,"version":"3.37.3"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gilead Sciences (US)","award":["IN-US-174-0209"],"award-info":[{"award-number":["IN-US-174-0209"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190581","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T13:40:17Z","timestamp":1515764417000},"page":"e0190581","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients"],"prefix":"10.1371","volume":"13","author":[{"given":"Heon Ju","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6165-8082","authenticated-orcid":true,"given":"Sang Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Oh","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Young","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Seok","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Jin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Hyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Ill","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Young","family":"Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Kuk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jhep.2013.06.007","article-title":"Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment","volume":"59","author":"WK Seto","year":"2013","journal-title":"J Hepatol"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.78.6.3906","article-title":"State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases","volume":"78","author":"C Brechot","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23246","article-title":"Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues","volume":"51","author":"F van Bommel","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.510270628","article-title":"Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group","volume":"27","author":"MI Allen","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"AS Lok","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2005.10.018","article-title":"Virologic response and resistance to adefovir in patients with chronic hepatitis B","volume":"44","author":"SK Fung","year":"2006","journal-title":"J Hepatol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1053\/j.gastro.2007.08.079","article-title":"Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients","volume":"133","author":"P Lampertico","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"AS Lok","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.26686","article-title":"No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B","volume":"59","author":"KM Kitrinos","year":"2014","journal-title":"Hepatology"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.cgh.2014.05.024","article-title":"No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B","volume":"12","author":"AC Corsa","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3350\/cmh.2016.22.1.18","article-title":"KASL clinical practice guidelines: management of chronic hepatitis B","volume":"22","year":"2016","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"NA Terrault","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1053\/j.gastro.2013.12.028","article-title":"Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B","volume":"146","author":"S Fung","year":"2014","journal-title":"Gastroenterology"},{"key":"ref15","article-title":"No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg- patients with chronic hepatitis B after 8 years of treatment","author":"Y Liu","year":"2016","journal-title":"Journal of viral hepatitis"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/gutjnl-2014-308435","article-title":"Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial","volume":"65","author":"YS Lim","year":"2016","journal-title":"Gut"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"AS Lok","year":"2007","journal-title":"Hepatology"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3748\/wjg.v21.i9.2746","article-title":"Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients","volume":"21","author":"DH Yang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref19","article-title":"The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy","author":"JH Kim","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"ref20","article-title":"Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients","author":"M Fasano","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003028","article-title":"Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV","volume":"3","author":"CJ Cohen","year":"2013","journal-title":"BMJ Open"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s12325-016-0337-2","article-title":"Renal Function in Nucleos(t)ide Analog-Treated Patients With Chronic Hepatitis B: A Systematic Literature Review and Network Meta-Analysis","volume":"33","author":"HL Chan","year":"2016","journal-title":"Adv Ther"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/655681","article-title":"Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients","volume":"51","author":"RD Cooper","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10620-014-3363-4","article-title":"Long-term treatment with tenofovir in Asian-American chronic hepatitis B patients is associated with abnormal renal phosphate handling","volume":"60","author":"C Tien","year":"2015","journal-title":"Dig Dis Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T12:01:21Z","timestamp":1540209681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190581"}},"subtitle":[],"editor":[{"given":"Jose Ignacio","family":"Herrero","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190581","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,1,12]]}}}